Extended SIR Prediction of the Epidemics Trend of COVID-19 in Italy and Compared With Hunan, China

Background: Coronavirus Disease 2019 (COVID-19) is currently a global public health threat. Outside of China, Italy is one of the countries suffering the most with the COVID-19 epidemic. It is important to predict the epidemic trend of the COVID-19 epidemic in Italy to help develop public health str...

Full description

Bibliographic Details
Main Authors: Jia Wangping, Han Ke, Song Yang, Cao Wenzhe, Wang Shengshu, Yang Shanshan, Wang Jianwei, Kou Fuyin, Tai Penggang, Li Jing, Liu Miao, He Yao
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-05-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fmed.2020.00169/full
id doaj-16c56bf9c7f448be9b0a1fb34b5e9481
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Jia Wangping
Jia Wangping
Han Ke
Song Yang
Cao Wenzhe
Wang Shengshu
Yang Shanshan
Wang Jianwei
Kou Fuyin
Tai Penggang
Li Jing
Liu Miao
He Yao
spellingShingle Jia Wangping
Jia Wangping
Han Ke
Song Yang
Cao Wenzhe
Wang Shengshu
Yang Shanshan
Wang Jianwei
Kou Fuyin
Tai Penggang
Li Jing
Liu Miao
He Yao
Extended SIR Prediction of the Epidemics Trend of COVID-19 in Italy and Compared With Hunan, China
Frontiers in Medicine
COVID-19
coronavirus
Italy
prediction
epidemics trend
author_facet Jia Wangping
Jia Wangping
Han Ke
Song Yang
Cao Wenzhe
Wang Shengshu
Yang Shanshan
Wang Jianwei
Kou Fuyin
Tai Penggang
Li Jing
Liu Miao
He Yao
author_sort Jia Wangping
title Extended SIR Prediction of the Epidemics Trend of COVID-19 in Italy and Compared With Hunan, China
title_short Extended SIR Prediction of the Epidemics Trend of COVID-19 in Italy and Compared With Hunan, China
title_full Extended SIR Prediction of the Epidemics Trend of COVID-19 in Italy and Compared With Hunan, China
title_fullStr Extended SIR Prediction of the Epidemics Trend of COVID-19 in Italy and Compared With Hunan, China
title_full_unstemmed Extended SIR Prediction of the Epidemics Trend of COVID-19 in Italy and Compared With Hunan, China
title_sort extended sir prediction of the epidemics trend of covid-19 in italy and compared with hunan, china
publisher Frontiers Media S.A.
series Frontiers in Medicine
issn 2296-858X
publishDate 2020-05-01
description Background: Coronavirus Disease 2019 (COVID-19) is currently a global public health threat. Outside of China, Italy is one of the countries suffering the most with the COVID-19 epidemic. It is important to predict the epidemic trend of the COVID-19 epidemic in Italy to help develop public health strategies.Methods: We used time-series data of COVID-19 from Jan 22 2020 to Apr 02 2020. An infectious disease dynamic extended susceptible-infected-removed (eSIR) model, which covers the effects of different intervention measures in dissimilar periods, was applied to estimate the epidemic trend in Italy. The basic reproductive number was estimated using Markov Chain Monte Carlo methods and presented using the resulting posterior mean and 95% credible interval (CI). Hunan, with a similar total population number to Italy, was used as a comparative item.Results: In the eSIR model, we estimated that the mean of basic reproductive number for COVID-19 was 4.34 (95% CI, 3.04–6.00) in Italy and 3.16 (95% CI, 1.73–5.25) in Hunan. There would be a total of 182 051 infected cases (95%CI:116 114–274 378) under the current country blockade and the endpoint would be Aug 05 in Italy.Conclusion: Italy's current strict measures can efficaciously prevent the further spread of COVID-19 and should be maintained. Necessary strict public health measures should be implemented as soon as possible in other European countries with a high number of COVID-19 cases. The most effective strategy needs to be confirmed in further studies.
topic COVID-19
coronavirus
Italy
prediction
epidemics trend
url https://www.frontiersin.org/article/10.3389/fmed.2020.00169/full
work_keys_str_mv AT jiawangping extendedsirpredictionoftheepidemicstrendofcovid19initalyandcomparedwithhunanchina
AT jiawangping extendedsirpredictionoftheepidemicstrendofcovid19initalyandcomparedwithhunanchina
AT hanke extendedsirpredictionoftheepidemicstrendofcovid19initalyandcomparedwithhunanchina
AT songyang extendedsirpredictionoftheepidemicstrendofcovid19initalyandcomparedwithhunanchina
AT caowenzhe extendedsirpredictionoftheepidemicstrendofcovid19initalyandcomparedwithhunanchina
AT wangshengshu extendedsirpredictionoftheepidemicstrendofcovid19initalyandcomparedwithhunanchina
AT yangshanshan extendedsirpredictionoftheepidemicstrendofcovid19initalyandcomparedwithhunanchina
AT wangjianwei extendedsirpredictionoftheepidemicstrendofcovid19initalyandcomparedwithhunanchina
AT koufuyin extendedsirpredictionoftheepidemicstrendofcovid19initalyandcomparedwithhunanchina
AT taipenggang extendedsirpredictionoftheepidemicstrendofcovid19initalyandcomparedwithhunanchina
AT lijing extendedsirpredictionoftheepidemicstrendofcovid19initalyandcomparedwithhunanchina
AT liumiao extendedsirpredictionoftheepidemicstrendofcovid19initalyandcomparedwithhunanchina
AT heyao extendedsirpredictionoftheepidemicstrendofcovid19initalyandcomparedwithhunanchina
_version_ 1724712339157024768
spelling doaj-16c56bf9c7f448be9b0a1fb34b5e94812020-11-25T02:56:46ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2020-05-01710.3389/fmed.2020.00169544001Extended SIR Prediction of the Epidemics Trend of COVID-19 in Italy and Compared With Hunan, ChinaJia Wangping0Jia Wangping1Han Ke2Song Yang3Cao Wenzhe4Wang Shengshu5Yang Shanshan6Wang Jianwei7Kou Fuyin8Tai Penggang9Li Jing10Liu Miao11He Yao12Beijing Key Laboratory of Aging and Geriatrics, National Clinical Research Center for Geriatrics Diseases, Second Medical Center of Chinese PLA General Hospital, Institute of Geriatrics, Beijing, ChinaDepartment of Military Medical Technology Support, School of Non-commissioned Officer, Army Medical University, Shijiazhuang, ChinaBeijing Key Laboratory of Aging and Geriatrics, National Clinical Research Center for Geriatrics Diseases, Second Medical Center of Chinese PLA General Hospital, Institute of Geriatrics, Beijing, ChinaBeijing Key Laboratory of Aging and Geriatrics, National Clinical Research Center for Geriatrics Diseases, Second Medical Center of Chinese PLA General Hospital, Institute of Geriatrics, Beijing, ChinaBeijing Key Laboratory of Aging and Geriatrics, National Clinical Research Center for Geriatrics Diseases, Second Medical Center of Chinese PLA General Hospital, Institute of Geriatrics, Beijing, ChinaBeijing Key Laboratory of Aging and Geriatrics, National Clinical Research Center for Geriatrics Diseases, Second Medical Center of Chinese PLA General Hospital, Institute of Geriatrics, Beijing, ChinaBeijing Key Laboratory of Aging and Geriatrics, National Clinical Research Center for Geriatrics Diseases, Second Medical Center of Chinese PLA General Hospital, Institute of Geriatrics, Beijing, ChinaBeijing Key Laboratory of Aging and Geriatrics, National Clinical Research Center for Geriatrics Diseases, Second Medical Center of Chinese PLA General Hospital, Institute of Geriatrics, Beijing, ChinaBeijing Key Laboratory of Aging and Geriatrics, National Clinical Research Center for Geriatrics Diseases, Second Medical Center of Chinese PLA General Hospital, Institute of Geriatrics, Beijing, ChinaBeijing Key Laboratory of Aging and Geriatrics, National Clinical Research Center for Geriatrics Diseases, Second Medical Center of Chinese PLA General Hospital, Institute of Geriatrics, Beijing, ChinaBeijing Key Laboratory of Aging and Geriatrics, National Clinical Research Center for Geriatrics Diseases, Second Medical Center of Chinese PLA General Hospital, Institute of Geriatrics, Beijing, ChinaBeijing Key Laboratory of Aging and Geriatrics, National Clinical Research Center for Geriatrics Diseases, Second Medical Center of Chinese PLA General Hospital, Institute of Geriatrics, Beijing, ChinaBeijing Key Laboratory of Aging and Geriatrics, National Clinical Research Center for Geriatrics Diseases, Second Medical Center of Chinese PLA General Hospital, Institute of Geriatrics, Beijing, ChinaBackground: Coronavirus Disease 2019 (COVID-19) is currently a global public health threat. Outside of China, Italy is one of the countries suffering the most with the COVID-19 epidemic. It is important to predict the epidemic trend of the COVID-19 epidemic in Italy to help develop public health strategies.Methods: We used time-series data of COVID-19 from Jan 22 2020 to Apr 02 2020. An infectious disease dynamic extended susceptible-infected-removed (eSIR) model, which covers the effects of different intervention measures in dissimilar periods, was applied to estimate the epidemic trend in Italy. The basic reproductive number was estimated using Markov Chain Monte Carlo methods and presented using the resulting posterior mean and 95% credible interval (CI). Hunan, with a similar total population number to Italy, was used as a comparative item.Results: In the eSIR model, we estimated that the mean of basic reproductive number for COVID-19 was 4.34 (95% CI, 3.04–6.00) in Italy and 3.16 (95% CI, 1.73–5.25) in Hunan. There would be a total of 182 051 infected cases (95%CI:116 114–274 378) under the current country blockade and the endpoint would be Aug 05 in Italy.Conclusion: Italy's current strict measures can efficaciously prevent the further spread of COVID-19 and should be maintained. Necessary strict public health measures should be implemented as soon as possible in other European countries with a high number of COVID-19 cases. The most effective strategy needs to be confirmed in further studies.https://www.frontiersin.org/article/10.3389/fmed.2020.00169/fullCOVID-19coronavirusItalypredictionepidemics trend